ABOUT THE PRODUCT
A lead drug candidate undergoing clinical trials for the treatment of cancer. It targets enzymes involved in cancer cell energy metabolism.
Information is owner-confirmed
Last updated 2 weeks ago
Price range
Other products/services from Cornerstone Pharmaceuticals
CB-839 (telaglenastat)
Pharmaceutical
N/A
Cornerstone Pharmaceuticals
United States (US)